{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Inherited white matter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_interferon_beta",
          "name": "Interferon beta"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_n_acetylcysteine",
          "name": "N-acetylcysteine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_hydroxyurea",
          "name": "Hydroxyurea"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_l_carbetapentane",
          "name": "L-carbetapentane"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic acid"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_dimethyl_fumarate",
          "name": "Dimethyl fumarate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_amifampridine",
          "name": "Amifampridine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_immunoglobulin_therapy",
          "name": "Immunoglobulin therapy"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot",
          "type": "Target",
          "label": "Off-target effects of interferon beta",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot2",
          "type": "Target",
          "label": "Oxidative stress related pathways",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse effects in inherited white matter disorders",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_interferon_beta",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能干扰正常神经活动"
        },
        {
          "source": "n_ot",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引起不良表型"
        },
        {
          "source": "drug_n_acetylcysteine",
          "target": "n_ot2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能激活抗氧化途径"
        },
        {
          "source": "drug_hydroxyurea",
          "target": "n_ot2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "或导致氧化应激增加"
        },
        {
          "source": "n_ot2",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能加重遗传性白质病的症状"
        }
      ],
      "set_weights": [
        {
          "edge_id": "e_k1",
          "weight": 0.85,
          "rationale": "不良反应及干扰机制被证实关键性高"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "drug efficacy vs safety",
          "pro_nodes": [
            "drug_interferon_beta"
          ],
          "con_nodes": [
            "n_ot",
            "n_adv"
          ],
          "note": "干扰正常功能的风险是否被低估"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "干扰素β可能对神经功能产生负面影响",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "氢氧化脲可能导致氧化应激，甚至加重病症",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "干扰素β在特定遗传性白质疾病中的作用机制是否被准确理解",
      "N-乙酰半胱氨酸及氢氧化脲对氧化应激的影响是否被低估"
    ],
    "falsification_tests": [
      "是否有研究显示干扰素β在遗传性白质病患者上的安全性数据",
      "是否存在有效的对照研究以支持此类疗法的长期安全性"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供具体机制路径确保无重大风险",
      "针对冲突热点进行后续讨论"
    ]
  }
}